Immuno-Oncology

Treating CINV Due to Immunotherapy and Targeted Therapy
Treating CINV Due to Immunotherapy and Targeted Therapy
BY PANELISTS: LEE S. SCHWARTZBERG, MD, UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER; ERIC ROELAND, MD, UNIVERSITY OF CALIFORNIA, SAN DIEGO; BETH EABY-SANDY, CRNP, O
Hair Repigmentation: A Marker of Anti-PD-1 Treatment Response?
Hair Repigmentation: A Marker of Anti-PD-1 Treatment Response?
BY LISA SCHULMEISTER, RN, MN, APRN-BC, FAAN
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.